TRIM52: A nuclear TRIM protein that positively regulates the nuclear factor-kappa B signaling pathway

被引:31
作者
Fan, Wenchun [1 ,2 ]
Liu, Tingting [1 ,2 ]
Li, Xiangmin [1 ,2 ,3 ]
Zhou, Yun [1 ,2 ]
Wu, Mengge [1 ,2 ]
Cui, Xiaofang [1 ,2 ]
Chen, Huanchun [1 ,2 ,3 ]
Qian, Ping [1 ,2 ,3 ]
机构
[1] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei Province, Peoples R China
[2] Huazhong Agr Univ, Div Anim Infect Dis, Coll Vet Med, Wuhan 430070, Peoples R China
[3] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China
基金
中国国家自然科学基金;
关键词
TRIM52; Nuclear factor-kappa B (NF-kappa B); Signaling transduction; Pro-inflammatory cytokine; FAMILY PROTEINS; INNATE IMMUNITY; AUTOPHAGY; CANCER; DEGRADATION; ACTIVATION; DISEASE; LIGASES; ROLES; ALPHA;
D O I
10.1016/j.molimm.2017.01.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Emerging evidence suggests that TRIM family proteins play a crucial role in regulating the NF-kappa B signaling pathway. TRIM52 is a novel noncanonical antiviral TRIM gene with a unique expanded RING domain. Information on the biological function of TRIM52 is limited. Herein, we demonstrated TRIM52 involvement in NF-kappa B activation. We found that TRIM52 overexpression specifically activated the NF-kappa B signal. TRIM52 overexpression can significantly induce TNF alpha and IL-6 expression. We also found that the RING domain of TRIM52 was essential for its activation of the NF-kappa B signal. Further study showed that TRIM52 overexpression did not affect the protein level of I kappa B alpha and phosphorylated p65 protein. We found that the pro-inflammatory cytokines TNF alpha and IL-6 could induce TRIM52 expression. Overall, these data suggested that TRIM52 was a positive regulator of the NF-kappa B pathway. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 43 条
[1]  
Amini-bavil-olyaee S., 2014, NAT COMMUN, V5, P4820
[2]   RETRACTED: Regulation of activity and function of the p52 NF-κB subunit following DNA damage (Retracted article. See vol. 13, pg. 2312, 2014) [J].
Barre, Benjamin ;
Coqueret, Olivier ;
Perkins, Neil D. .
CELL CYCLE, 2010, 9 (24) :4795-4804
[3]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[4]   Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease [J].
Brynskov, J ;
Foegh, P ;
Pedersen, G ;
Ellervik, C ;
Kirkegaard, T ;
Bingham, A ;
Saermark, T .
GUT, 2002, 51 (01) :37-43
[5]   Human TRIM Gene Expression in Response to Interferons [J].
Carthagena, Laetitia ;
Bergamaschi, Anna ;
Luna, Joseph M. ;
David, Annie ;
Uchil, Pradeep D. ;
Margottin-Goguet, Florence ;
Mothes, Walther ;
Hazan, Uriel ;
Transy, Catherine ;
Pancino, Gianfranco ;
Nisole, Sebastien .
PLOS ONE, 2009, 4 (03)
[6]  
Egan L, 2009, REV SYST BIOL MED, V1, P107
[7]   TRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2A [J].
Fan, Wenchun ;
Wu, Mengge ;
Qian, Suhong ;
Zhou, Yun ;
Chen, Huanchun ;
Li, Xiangmin ;
Qian, Ping .
SCIENTIFIC REPORTS, 2016, 6
[8]   Swine TRIM21 restricts FMDV infection via an intracellular neutralization mechanism [J].
Fan, Wenchun ;
Zhang, Dong ;
Qian, Ping ;
Qian, Suhong ;
Wu, Mengge ;
Chen, Huanchun ;
Li, Xiangmin .
ANTIVIRAL RESEARCH, 2016, 127 :32-40
[9]   Early evidence for the role of TRIM29 in multiple cancer models [J].
Hatakeyama, Shigetsugu .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (07) :767-770
[10]   TRIM proteins and cancer [J].
Hatakeyama, Shigetsugu .
NATURE REVIEWS CANCER, 2011, 11 (11) :792-804